Literature DB >> 22203491

The dynamic interplay in chromatin remodeling factors polycomb and trithorax proteins in response to DNA damage.

Shuang Liu1, Yongguang Tao, Xiang Chen, Ya Cao.   

Abstract

The dynamic interplay in polycomb group (PcG) and trithorax group (TrxG) proteins in response to DNA damage directly involves in the DNA double strand breaks (DSBs) sites and potentially function in both homologous recombination (HR) and nonhomologous end joining (NHEJ) pathways. The process includes chromatin remodeling that is a major mechanism used by cells to relax chromatin in DNA damage response (DDR) and repair. PcGs show resistance ability to the process while, some tumor suppressor genes involves in the DDR and repair by interacting with TrxGs. Understanding how the dynamic interplay in PcGs and TrxGs impacts on DDR will shed light on the mechanisms of carcinogenesis and develop a new target from anti-DDR related drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203491     DOI: 10.1007/s11033-011-1435-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  63 in total

1.  The ACF1 complex is required for DNA double-strand break repair in human cells.

Authors:  Li Lan; Ayako Ui; Satoshi Nakajima; Kotomi Hatakeyama; Mikiko Hoshi; Reiko Watanabe; Susan M Janicki; Hideaki Ogiwara; Takashi Kohno; Shin-Ichiro Kanno; Akira Yasui
Journal:  Mol Cell       Date:  2010-12-22       Impact factor: 17.970

2.  KAP-1 phosphorylation regulates CHD3 nucleosome remodeling during the DNA double-strand break response.

Authors:  Aaron A Goodarzi; Thomas Kurka; Penelope A Jeggo
Journal:  Nat Struct Mol Biol       Date:  2011-06-05       Impact factor: 15.369

3.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

Review 4.  Chaperoning histones during DNA replication and repair.

Authors:  Monica Ransom; Briana K Dennehey; Jessica K Tyler
Journal:  Cell       Date:  2010-01-22       Impact factor: 41.582

5.  BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery.

Authors:  Sabrina Facchino; Mohamed Abdouh; Wassim Chatoo; Gilbert Bernier
Journal:  J Neurosci       Date:  2010-07-28       Impact factor: 6.167

6.  Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha).

Authors:  J C Reyes; J Barra; C Muchardt; A Camus; C Babinet; M Yaniv
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

7.  Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells.

Authors:  Jamy C Peng; Anton Valouev; Tomek Swigut; Junmei Zhang; Yingming Zhao; Arend Sidow; Joanna Wysocka
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

Review 8.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

9.  WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity.

Authors:  Andrew Xiao; Haitao Li; David Shechter; Sung Hee Ahn; Laura A Fabrizio; Hediye Erdjument-Bromage; Satoko Ishibe-Murakami; Bin Wang; Paul Tempst; Kay Hofmann; Dinshaw J Patel; Stephen J Elledge; C David Allis
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962

10.  Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis.

Authors:  P Nagarajan; T M Onami; S Rajagopalan; S Kania; R Donnell; S Venkatachalam
Journal:  Oncogene       Date:  2009-01-12       Impact factor: 9.867

View more
  1 in total

1.  Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8.

Authors:  Y Jiang; B Yan; W Lai; Y Shi; D Xiao; J Jia; S Liu; H Li; J Lu; Z Li; L Chen; X Chen; L Sun; K Muegge; Y Cao; Y Tao
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.